No class action for Vioxx refunds to consumers, US court says
This article was originally published in Scrip
Executive Summary
A New Jersey state court has denied plaintiffs' request to certify a class of consumers who sought to recoup out-of-pocket expenses for their use of Merck & Co's withdrawn painkiller Vioxx (rofecoxib).